Recombinant Pseudomonas putida Probable malate dehydrogenase (mdh)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, serving as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type will be determined during production. If you require a specific tag, please inform us for preferential development.
Synonyms
mdh; PP_0654; Probable malate dehydrogenase; EC 1.1.1.37
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-278
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440)
Target Names
mdh
Target Protein Sequence
MDVQGELAQG KALDVWQAAV DSGSDTHVHG GAKAEMLEGS ELVVITAGVP RKPGQSRQDV LSTNLPILDS IMADIKHHAP TATVLVVSNP VDVLTYRAWS VSGQGRDKVF GQAGVLDTAR MKCFIAEQTG FSARDITALV LGGHGDSMVP LMRYCQIGSV PLSHFLSSEQ IEQIVERTRK GGGEILGLKK TGSACDAPGV AIAQMVDAIA NGRNRILPAV AILEGEYGRT DIAMGVPCVL AEKGLARIIE LPLDAQEQAM FDHSADQVAR DIAEMKAL
Uniprot No.

Target Background

Function

Catalyzes the reversible oxidation of malate to oxaloacetate.

Database Links

KEGG: ppu:PP_0654

STRING: 160488.PP_0654

Protein Families
LDH/MDH superfamily

Q&A

What is the molecular structure of P. putida MDH and how does it differ from other MDH enzymes?

P. putida MDH is a membrane-associated protein belonging to the flavin mononucleotide-dependent α-hydroxy acid oxidase/dehydrogenase family, which differs significantly from the more well-characterized soluble members of this family, such as glycolate oxidase (GOX) from spinach . The membrane association of P. putida MDH has been mapped to a specific segment of approximately 39 amino acids within the protein sequence. When this segment is deleted or modified, membrane localization is disrupted .

How can I clone and express recombinant P. putida MDH?

To clone and express recombinant P. putida MDH, you should follow this methodological approach:

  • Gene amplification: Amplify the full-length mdh gene (approximately 981 bp) using PCR with high-fidelity DNA polymerase and gene-specific primers containing appropriate restriction sites (e.g., BamHI and HindIII) .

  • Cloning: First clone the amplified gene into a cloning vector (such as pSK+) and transform into E. coli DH5α cells. Screen positive clones using blue-white screening with X-gal and IPTG on ampicillin-containing plates. Confirm correct clones by restriction digestion and sequencing .

  • Sub-cloning into expression vector: After sequence verification, sub-clone the mdh gene into an expression vector like pET28a(+) at the defined restriction sites to create a His-tagged fusion protein .

  • Protein expression: Transform the recombinant plasmid into an expression host such as E. coli BL21(DE3) codon(+) cells. Grow transformed cells in LB media containing appropriate antibiotics (kanamycin at 50 μg/mL) at 37°C until OD600 reaches 0.6-0.8. Then induce protein expression with IPTG (1.0 mM) and incubate at lower temperature (20°C) for 24 hours to enhance soluble protein production .

  • Protein purification: Harvest cells by centrifugation and resuspend in buffer containing protease inhibitors (e.g., PMSF). Lyse cells by sonication and clarify the lysate by centrifugation. Purify the His-tagged protein using Ni²⁺-NTA affinity chromatography, washing with increasing concentrations of imidazole and eluting with buffer containing 300 mM imidazole .

  • Protein characterization: Confirm protein purity by SDS-PAGE and determine protein concentration using the Bradford method. Remove imidazole by dialysis in appropriate buffer (e.g., phosphate buffer pH 7.6 with 150 mM NaCl and 10% glycerol) .

What are the optimal conditions for assaying P. putida MDH activity?

The optimal conditions for assaying P. putida MDH activity are as follows:

  • pH: The enzyme shows maximum activity at approximately pH 10.0 for the oxidation of malate to oxaloacetate. At pH values below 7.0 or above 10.0, there is almost complete loss of enzymatic activity . For the reduction of oxaloacetate to malate (forward reaction), a more neutral pH is typically optimal.

  • Temperature: The activity of MDH increases with temperature up to 40°C, after which the activity decreases dramatically due to thermal denaturation of the enzyme .

  • Cofactor specificity: P. putida MDH is specific for NAD⁺/NADH as cofactors and shows no activity with NADP⁺/NADPH .

  • Assay components: For the forward reaction (oxaloacetate to malate), the assay typically includes oxaloacetate as substrate and NADH as cofactor in an appropriate buffer. For the reverse reaction (malate to oxaloacetate), the assay includes malate as substrate and NAD⁺ as cofactor. The reaction can be monitored spectrophotometrically by measuring the change in absorbance at 340 nm due to the oxidation/reduction of the nicotinamide cofactor .

  • Kinetic parameters: The enzyme follows Michaelis-Menten kinetics for both forward and reverse reactions, with specific Km values for substrates and cofactors that can be determined through initial velocity studies .

How can I create soluble variants of P. putida MDH while maintaining its catalytic properties?

Creating soluble variants of membrane-associated P. putida MDH while preserving its catalytic properties requires targeted protein engineering focused on the membrane-binding segment. Based on research findings, you can use the following methodological approach:

What molecular dynamics insights can help understand P. putida MDH structure-function relationships?

Molecular dynamics (MD) simulations provide valuable insights into the structure-function relationships of P. putida MDH. Based on studies of related MDH enzymes, the following methodological approach can be applied:

How does the kinetic mechanism of P. putida MDH compare with MDHs from other organisms?

The kinetic mechanism of P. putida MDH can be compared with MDHs from other organisms through detailed enzyme kinetic analysis:

  • Determination of kinetic parameters: Measure the kinetic constants (Km, kcat, kcat/Km) for P. putida MDH in both forward (oxaloacetate to malate) and reverse (malate to oxaloacetate) reactions using initial velocity studies. The table below illustrates comparative kinetic parameters for MDHs from different sources:

OrganismReaction DirectionSubstrateKm (mM)kcat (s⁻¹)kcat/Km (s⁻¹·mM⁻¹)
P. putidaForwardOxaloacetate~0.1-0.5~10-50~100-500
P. putidaForwardNADH~0.02-0.1--
P. putidaReverseMalate~1-5~5-20~1-10
P. putidaReverseNAD⁺~0.1-0.5--
F. giganticaForwardOxaloacetateSpecific valuesdeterminedexperimentally
F. giganticaReverseMalateSpecific valuesdeterminedexperimentally
Other organismsVariousVariousVariableVariableVariable

Note: The exact values for P. putida MDH would need to be determined experimentally, as the search results don't provide specific kinetic parameters for this enzyme. The ranges given are typical for MDHs based on information from related enzymes .

  • Cofactor specificity: Unlike some dehydrogenases that can utilize both NAD⁺/NADH and NADP⁺/NADPH, P. putida MDH, similar to MDHs from other organisms, shows strict specificity for NAD⁺/NADH and exhibits no activity with NADP⁺/NADPH .

  • pH dependence: The pH profile of P. putida MDH activity in the reverse direction (malate to oxaloacetate) shows maximum activity at approximately pH 10.0, with significant loss of activity below pH 7.0 and above pH 10.0. This pH dependence may differ from MDHs from other organisms, reflecting adaptations to their specific cellular environments .

  • Temperature dependence: P. putida MDH shows increasing activity up to 40°C, after which activity decreases rapidly. This temperature profile reflects the mesophilic nature of P. putida and may differ from MDHs from thermophilic or psychrophilic organisms .

  • Reaction mechanism: The kinetic mechanism can be further elucidated through product inhibition studies and isotope exchange experiments to determine if the reaction follows an ordered or random sequential mechanism, or a ping-pong mechanism, which can then be compared with the mechanisms of MDHs from other organisms.

What are the effects of metal ions on P. putida MDH activity and stability?

The effects of metal ions on P. putida MDH activity and stability can be systematically investigated using the following methodological approach:

  • Metal ion screening: Evaluate the effect of various metal ions (e.g., Zn²⁺, Cu²⁺, Cd²⁺, Mg²⁺, Ca²⁺, Mn²⁺, Fe²⁺, Co²⁺, Ni²⁺) on enzyme activity by including these ions at different concentrations in standard enzyme assays. This screening can identify both inhibitory and stimulatory effects .

  • Dose-response relationships: For metal ions showing significant effects, determine dose-response relationships to calculate IC₅₀ values (for inhibitors) or activation constants (for stimulators). This information helps quantify the sensitivity of the enzyme to specific metal ions.

  • Mechanism of inhibition/activation: Perform kinetic studies in the presence of metal ions to determine the mechanism of inhibition (competitive, noncompetitive, uncompetitive, or mixed) or activation. This involves analyzing the effects of metal ions on Km and Vmax parameters through Lineweaver-Burk or other appropriate plots.

  • Structural stability studies: Investigate the effects of metal ions on enzyme structural stability using:

    • Thermal stability assays to determine changes in melting temperature (Tm)

    • Circular dichroism spectroscopy to assess secondary structure changes

    • Fluorescence spectroscopy to evaluate tertiary structure alterations

    • Limited proteolysis to identify regions of altered flexibility or exposure

  • Recovery studies: Determine whether the effects of metal ions are reversible by testing if enzyme activity can be restored after metal ion removal (e.g., through dialysis or addition of chelating agents like EDTA).

  • Molecular docking and simulations: Use computational approaches to predict metal binding sites and simulate the effects of metal binding on protein conformation and dynamics. These studies can provide molecular-level insights into how metals affect enzyme function .

  • Site-directed mutagenesis: If specific metal-binding sites are identified or predicted, use site-directed mutagenesis to modify these sites and evaluate the resulting changes in metal sensitivity, which can confirm the importance of specific residues in metal interactions.

While P. putida is known to harbor metal resistance genes and can grow in environments with excess metals , the specific effects of metals on P. putida MDH have not been extensively characterized in the provided search results. The methodological approach outlined above would enable comprehensive investigation of these effects.

What are the key considerations for optimizing expression of soluble recombinant P. putida MDH?

Optimizing expression of soluble recombinant P. putida MDH requires careful consideration of several parameters:

  • Expression system selection: Choose an appropriate expression system based on your research needs. E. coli BL21(DE3) or its derivatives (such as BL21(DE3) codon+) are often suitable for expressing bacterial proteins like P. putida MDH . Consider specialized strains for proteins with rare codons or those that tend to form inclusion bodies.

  • Vector design: Select an expression vector with:

    • An appropriate promoter (T7 promoter is commonly used for high expression)

    • Fusion tags to enhance solubility (His-tag for purification, MBP or SUMO for solubility)

    • Appropriate antibiotic resistance markers (e.g., kanamycin resistance in pET28a+)

  • Induction conditions optimization:

    • Temperature: Lower temperatures (15-25°C) often favor soluble protein production over inclusion body formation. For P. putida MDH, induction at 20°C has been shown to be effective

    • IPTG concentration: Test various concentrations (0.1-1.0 mM) to find the optimal balance between expression level and solubility. 1.0 mM IPTG has been used successfully for MDH expression

    • Induction time: Extended induction periods (16-24 hours) at lower temperatures can improve soluble protein yield

  • Growth media optimization:

    • Rich media (such as LB or TB) typically provide higher cell densities and protein yields

    • Defined media may be preferred for specific experimental requirements

    • Supplements such as glucose or glycerol can influence expression levels

  • Solubility enhancement strategies:

    • Co-expression with chaperones (GroEL/GroES, DnaK/DnaJ) can improve folding

    • Addition of compatible solutes (glycine betaine, proline) or mild solubilizing agents to the growth medium

    • For membrane-associated proteins like native P. putida MDH, consider protein engineering approaches to remove membrane-binding segments, as demonstrated with the MDH-GOX2 chimera

  • Dealing with membrane association: If expression of native P. putida MDH results in membrane association that complicates purification:

    • Create chimeric constructs like MDH-GOX2 by replacing the membrane-binding segment (approximately 39 amino acids) with the corresponding segment from a soluble homolog

    • Verify that the chimeric construct retains catalytic properties similar to the wild-type enzyme

  • Optimization monitoring: Monitor the optimization process by:

    • Analyzing total vs. soluble protein by SDS-PAGE

    • Assessing enzyme activity in crude extracts

    • Performing small-scale purifications to evaluate yield and purity

How can I distinguish between genuine P. putida MDH activity and potential contaminating enzyme activities?

Distinguishing between genuine P. putida MDH activity and potential contaminating enzyme activities requires a multi-faceted approach:

  • Substrate specificity analysis: P. putida MDH catalyzes the reversible conversion of malate to oxaloacetate using NAD⁺/NADH as cofactors. Test activity with structurally related compounds (e.g., lactate, isocitrate) to establish substrate specificity profile. True MDH should show high specificity for malate/oxaloacetate .

  • Cofactor specificity: MDH is highly specific for NAD⁺/NADH and should show little to no activity with NADP⁺/NADPH. This can help distinguish MDH from other dehydrogenases that may utilize NADP⁺/NADPH .

  • Inhibitor sensitivity profiling: Test sensitivity to known MDH inhibitors (e.g., oxalate, tartronate) and compare with reported inhibition patterns for authentic MDH. Also test with inhibitors of related enzymes that might be present as contaminants.

  • Kinetic parameter determination: Determine kinetic parameters (Km, Vmax) for both substrates and cofactors. Compare these values with published parameters for authentic P. putida MDH or closely related MDHs. Significant deviations may indicate contaminating activities.

  • Immunological methods: If antibodies against P. putida MDH or related MDHs are available, use Western blotting or immunoprecipitation to confirm the identity of the enzyme. Immunodepletion can also help determine what fraction of the observed activity is attributable to MDH.

  • Heat inactivation studies: Different enzymes often have different thermal stability profiles. Perform heat inactivation studies at various temperatures and compare the inactivation profile with that expected for authentic MDH.

  • Protein purity assessment: Use multiple techniques to assess protein purity:

    • SDS-PAGE with silver staining (can detect contaminating proteins down to nanogram levels)

    • Size exclusion chromatography to verify the homogeneity of the protein preparation

    • Mass spectrometry to confirm the identity and purity of the protein

  • Controls with defined mutations: Express and purify MDH variants with mutations in catalytic residues. These should show reduced or eliminated activity compared to wild-type enzyme. If activity persists despite mutations that should abolish MDH function, contaminating activities may be present.

  • Comparative analysis with commercial MDH: Compare the properties of your recombinant P. putida MDH with commercially available MDH (if available) as a reference standard.

What computational tools and approaches are most effective for analyzing the structural dynamics of P. putida MDH?

Analyzing the structural dynamics of P. putida MDH requires sophisticated computational tools and approaches:

  • Homology modeling: For P. putida MDH without an experimental structure, develop accurate homology models using tools such as:

    • MODELLER, SWISS-MODEL, or I-TASSER for model building

    • PyMOL, Chimera, or VMD for visualization and structural analysis

    • PROCHECK, VERIFY3D, or MolProbity for model validation

  • Molecular dynamics simulations: Perform MD simulations using specialized software to understand protein dynamics:

    • GROMACS, AMBER, or NAMD for simulation of protein dynamics

    • Appropriate force fields such as GROMOS 9653a6 for protein topology generation

    • Analysis tools like g_rmsd, g_rmsf, g_gyrate, g_hbond for trajectory analysis

  • Simulation protocol optimization:

    • Proper system preparation with appropriate solvation and neutralization

    • Energy minimization to relieve steric clashes (< 1,000 kJ mol⁻¹ nm⁻¹)

    • Equilibration in NVT and NPT ensembles before production runs

    • Production simulations of sufficient length (200+ ns) to capture relevant dynamics

  • Advanced trajectory analysis:

    • Principal Component Analysis (PCA) using tools like g_anaeig to identify dominant modes of motion

    • Dynamic Cross-Correlation Maps (DCCM) to identify correlated motions between residues

    • Network analysis to identify communication pathways within the protein

    • Clustering analysis to identify representative conformations

  • Substrate and cofactor docking: Use molecular docking to predict binding modes:

    • AutoDock, DOCK, or Glide for rigid receptor docking

    • Induced-fit docking methods to account for conformational changes upon binding

    • Analysis of docking poses using scoring functions and visual inspection

  • Analysis of protein-ligand interactions: Characterize the interactions between MDH and its substrates/cofactors:

    • Hydrogen bond analysis to identify key interactions

    • Binding free energy calculations using MM-PBSA or MM-GBSA methods

    • Decomposition of binding energies to identify key contributing residues

  • Secondary structure analysis: Track changes in secondary structure elements during simulations:

    • DSSP algorithm for secondary structure assignment

    • Analysis of secondary structure evolution over time to identify stable/unstable regions

    • Correlation of secondary structure changes with functional movements

  • Comparative analysis with homologous enzymes: Compare the dynamics of P. putida MDH with MDHs from other organisms to identify conserved dynamic features that may be essential for function versus unique features that may contribute to specific adaptations.

The data from these computational analyses can provide valuable insights into the structure-function relationships of P. putida MDH, guiding experimental design and interpretation of biochemical data.

How can engineered variants of P. putida MDH be utilized in metabolic engineering applications?

Engineered variants of P. putida MDH offer significant potential for metabolic engineering applications:

What are the future research directions for understanding the role of MDH in P. putida metal resistance mechanisms?

Future research directions for understanding the role of MDH in P. putida metal resistance mechanisms include:

  • Transcriptomic and proteomic analyses: Investigate changes in MDH expression levels in response to various metal stressors using:

    • RNA-Seq to quantify transcriptional changes

    • Quantitative proteomics to measure protein abundance changes

    • Correlation of MDH expression with known metal resistance genes

  • Functional genomics approaches: Apply high-throughput screening methods to elucidate MDH's role:

    • Tn-seq screens in metal-rich environments to assess the importance of MDH and related genes for metal resistance

    • CRISPR-Cas9 based genome editing to create precise MDH mutants

    • Overexpression and deletion studies to directly assess MDH's contribution to metal resistance

  • Metabolic flux analysis: Determine how metal stress affects carbon flux through MDH using:

    • ¹³C metabolic flux analysis to trace carbon flow through central metabolism

    • Metabolomics to identify changes in malate, oxaloacetate, and related metabolites

    • Integration with computational metabolic models to predict system-wide effects

  • Metal-enzyme interaction studies: Characterize direct interactions between metals and MDH:

    • In vitro enzyme assays with varying metal concentrations to determine activation/inhibition patterns

    • Metal binding studies using isothermal titration calorimetry or other biophysical methods

    • Structural studies of MDH-metal complexes using X-ray crystallography or cryo-EM

  • Integration with metal homeostasis pathways: Investigate the relationship between MDH and known metal resistance mechanisms:

    • Connection to efflux systems like CzcA-1, CadA-3, and PcoA2

    • Interaction with metal-responsive transcriptional regulators such as CadR

    • Potential role in metal detoxification or sequestration pathways

  • Comparative studies across Pseudomonas species: Compare MDH characteristics across Pseudomonas species with different metal resistance profiles to identify adaptations specific to P. putida.

  • Engineering MDH for enhanced metal resistance: Develop MDH variants with:

    • Improved stability in the presence of toxic metals

    • Altered metal cofactor requirements

    • Enhanced catalytic efficiency under metal stress conditions

  • Systems biology integration: Develop comprehensive models that integrate:

    • Transcriptomic and proteomic data

    • Metabolic flux information

    • Metal homeostasis networks

    • Central carbon metabolism pathways

This research would not only advance our understanding of P. putida's metal resistance mechanisms but could also lead to applications in bioremediation of metal-contaminated environments and the development of robust microbial cell factories for industrial biotechnology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.